May 31, 2020

Tempus – $100 Million


Chicago, Ill ; 03/16/2020

Amount Funded: $100 Million

Type: Series G

Participating Investor(s):  Franklin Templeton, Novo Holdings, T. Rowe Price, NEA, Baillie Gifford

Total Funding to Date: $600 Million+

Company Description: From the website: “Tempus is a technology company that has built the world’s largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians, and researchers.”

What funding will be used for:  To expand its areas of expertise from cancer to diabetes, depression, cardiology and other health issues. 


“As a leader in bringing the power and promise of artificial intelligence to healthcare, we’re mindful of the size and scope of the opportunity in front us. The latest fundraising will enhance our ability to forward invest in new disease areas and geographies.”

-Eric Lefkofsky, founder. Tempus (to ChicagoInno)


  1. . Tempus’ current valuation is $5 billion (as of 3/16/20)
  2. Some data on this page provided by ChicagoInno

Data provided by respective company (unless otherwise noted) and researched by StartupsOne for accuracy.



StartupsOne features relevant, focused news on venture capital funding of technology oriented startup businesses based in North America.

View all posts by StartupsOne →